ICCC vs GILD: Which Stock is Better?
Side-by-side comparison of Immucell Corp and Gilead Sciences Inc in 2026
ICCC
Immucell Corp
$7.88
GILD
Gilead Sciences Inc
$137.64
Key Metrics Comparison
| Metric | ICCC | GILD | Winner |
|---|---|---|---|
| Market Cap | $68.21M | $171.97B | GILD |
| P/E Ratio | N/A | 20.44 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | -0.0% | 0.0% | GILD |
| Gross Margin | 41.4% | 78.8% | GILD |
Analyze ICCC
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ICCC or GILD a better investment?
Comparing ICCC and GILD: Immucell Corp has a market cap of $68.21M while Gilead Sciences Inc has $171.97B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ICCC and GILD?
ICCC (Immucell Corp) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ICCC or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ICCC or GILD?
GILD has higher revenue growth at 0.0% vs -0.0% for ICCC.
Which company is more profitable: ICCC or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 41.4% for ICCC.
Which is the larger company: ICCC or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $171.97B compared to $68.21M for ICCC.
Should I buy ICCC or GILD in 2026?
Both ICCC and GILD have investment merit. ICCC trades at $7.88 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ICCC and GILD stock?
Key differences: Market Cap ($68.21M vs $171.97B), P/E Ratio (N/A vs 20.4x), Revenue Growth (-0.0% vs 0.0%), Gross Margin (41.4% vs 78.8%).